Our investigation has introduced an innovative risk prognostication model for cholesterol metabolism and verified the biological conduct of NPC2, a pivotal gene in cholesterol metabolism, thereby offering fresh modalities and viewpoints for gastric cancer treatment. This evidence concerns the gene NPC2 and gastric cancer.